We are live on ! Find out more
FC

FIC Capital Portfolio holdings

AUM $262M
1-Year Est. Return 34.37%
This Fund
S&P 500
This Quarter Est. Return
+1.16%
1 Year Est. Return
+34.37%
3 Year Est. Return
+49.66%
5 Year Est. Return
10 Year Est. Return
AUM
$211M
AUM Growth
+$4.62M
Cap. Flow
-$1.23B
Cap. Flow %
-580.76%
Top 10 Hldgs %
33.9%
Holding
125
New
9
Increased
28
Reduced
56
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 21.9%
2 Technology 16.16%
3 Communication Services 14.94%
4 Financials 9.31%
5 Real Estate 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TFC icon
26
Truist Financial
TFC
$62.6B
$2.74M 1.3%
76,915
+14,705
+24% +$514K
APC
27
DELISTED
Anadarko Petroleum
APC
$2.64M 1.25%
49,580
+6,995
+16% +$355K
TLP
28
DELISTED
Transmontaigne
TLP
$2.64M 1.25%
64,192
+2,737
+4% +$108K
AAPL icon
29
Apple
AAPL
$4.78T
$2.39M 1.13%
100,088
-5,396
-5% -$134K
AES icon
30
AES
AES
$10.5B
$2.36M 1.12%
188,750
-1,900
-1% -$21.4K
T icon
31
AT&T
T
$152B
$2.3M 1.09%
70,465
-3,872
-5% -$115K
LGF
32
DELISTED
Lions Gate Entertainment
LGF
$2.23M 1.06%
110,125
+7,590
+7% +$159K
RMBS icon
33
Rambus
RMBS
$11.3B
$2.17M 1.03%
180,000
KO icon
34
Coca-Cola
KO
$351B
$1.99M 0.94%
43,798
+37,372
+582% +$1.69M
FDX icon
35
FedEx
FDX
$73.3B
$1.92M 0.91%
12,655
PFE icon
36
Pfizer
PFE
$142B
$1.91M 0.9%
57,016
-332
-0.6% -$10.6K
ELV icon
37
Elevance Health
ELV
$83.3B
$1.9M 0.9%
14,485
+5,465
+61% +$748K
BIIB icon
38
Biogen
BIIB
$30B
$1.84M 0.87%
7,602
-126
-2% -$33.2K
APA icon
39
APA Corp
APA
$12.4B
$1.84M 0.87%
32,986
+785
+2% +$42.7K
COF icon
40
Capital One
COF
$128B
$1.82M 0.86%
28,660
-9,445
-25% -$658K
NVS icon
41
Novartis
NVS
$289B
$1.82M 0.86%
24,618
+298
+1% +$20.6K
ILMN icon
42
Illumina
ILMN
$28.1B
$1.78M 0.84%
13,032
-339
-3% -$48.2K
CVS icon
43
CVS Health
CVS
$137B
$1.77M 0.84%
18,441
-885
-5% -$88.2K
TD icon
44
Toronto Dominion Bank
TD
$200B
$1.73M 0.82%
40,400
LAB icon
45
Standard BioTools
LAB
$332M
$1.7M 0.81%
188,700
COO icon
46
Cooper Companies
COO
$13.9B
$1.66M 0.79%
38,768
-20
-0.1% -$800
PG icon
47
Procter & Gamble
PG
$348B
$1.61M 0.76%
19,077
-1,354
-7% -$111K
MRK icon
48
Merck
MRK
$310B
$1.47M 0.7%
26,717
-2,861
-10% -$152K
OXY icon
49
Occidental Petroleum
OXY
$55.1B
$1.46M 0.69%
19,250
+4,195
+28% +$313K
HSIC icon
50
Henry Schein
HSIC
$9.85B
$1.33M 0.63%
19,153
-408
-2% -$27.6K

Similar funds

FIC Capital's Q2 2016 Portfolio in Review

As of Q2 2016, FIC Capital held 125 positions worth $211M, up 2.2% from $207M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

FIC Capital withdrew a net $1.23B in Q2 2016, closing 4 positions and reducing 56 holdings. Its most notable exit was Affymetrix Inc, an estimated $2.03M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Communication Services.

Against the trend, FIC Capital opened a new position in Allergan plc worth $1.23M.

  • FIC Capital's largest Q2 2016 buy was Allergan plc: 5,311 shares worth $1.23M.
  • FIC Capital added most to Vanguard Total Bond Market in Q2 2016, an estimated $2.83M increase.
  • FIC Capital's biggest Q2 2016 reduction was Intel, cutting an estimated $954K.
  • FIC Capital fully exited Affymetrix Inc in Q2 2016, selling an estimated $2.03M.
  • FIC Capital's ten largest holdings make up 34% of its $211M portfolio in Q2 2016.
  • FIC Capital opened 9 new positions and closed 4 in Q2 2016.
  • FIC Capital's portfolio value rose 2.2% quarter-over-quarter to $211M.

Based on FIC Capital's 13F filing for Q2 2016, filed 11 Aug 2016.